{"title":"A Narrative Review and Risk-Stratification Framework for Preventing LNG-IUS Expulsion in Adenomyosis.","authors":"Jin Zhao, Jianliang Chen, Xiaoe Wang, Huabin Wang","doi":"10.2147/TCRM.S566786","DOIUrl":null,"url":null,"abstract":"<p><p>Levonorgestrel-releasing intrauterine system (LNG-IUS) expulsion rates are markedly elevated (15-37.5%) in patients with adenomyosis compared to those with normal uteri (3-10%), significantly compromising treatment efficacy and adherence. Existing evidence on risk factor mitigation is fragmented, lacking a structured management framework. This narrative review synthesizes current literature to identify key determinants of expulsion-including uterine enlargement, intracavitary lesions, and insertion techniques-and evaluates preventive strategies such as GnRH-agonist pretreatment and imaging-guided placement. Its primary aim is to propose a novel, three-tiered risk-stratification model that tailors management (conventional, augmented, or advanced fixation approaches) to individual patient profiles based on anatomical, procedural, and clinical factors. This structured approach seeks to optimize LNG-IUS retention and resource allocation. Prospective validation through randomized controlled trials remains essential to establish evidence-based, personalized protocols.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"22 ","pages":"566786"},"PeriodicalIF":2.6000,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12998664/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutics and Clinical Risk Management","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/TCRM.S566786","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Levonorgestrel-releasing intrauterine system (LNG-IUS) expulsion rates are markedly elevated (15-37.5%) in patients with adenomyosis compared to those with normal uteri (3-10%), significantly compromising treatment efficacy and adherence. Existing evidence on risk factor mitigation is fragmented, lacking a structured management framework. This narrative review synthesizes current literature to identify key determinants of expulsion-including uterine enlargement, intracavitary lesions, and insertion techniques-and evaluates preventive strategies such as GnRH-agonist pretreatment and imaging-guided placement. Its primary aim is to propose a novel, three-tiered risk-stratification model that tailors management (conventional, augmented, or advanced fixation approaches) to individual patient profiles based on anatomical, procedural, and clinical factors. This structured approach seeks to optimize LNG-IUS retention and resource allocation. Prospective validation through randomized controlled trials remains essential to establish evidence-based, personalized protocols.
期刊介绍:
Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.
The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.
As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.
The journal does not accept study protocols, animal-based or cell line-based studies.